Eastman Q3 2026 slides show margin gains despite estimate miss

Eastman Chemical (EMN) reported Q3 2026 earnings of $1.84/share, missing estimates of $1.94, with revenue at $2.39B, slightly below the $2.41B forecast. Despite this, margins improved, with adjusted EBIT rising to $305M (12.8% margin) from $210M (9.5%) a year ago. The company cited higher selling prices, favorable price-cost dynamics, and cost reduction initiatives as drivers. Segment performance varied, with Additives & Functional Products showing the strongest results.

Original reporting
Published Nov 1, 2026, 11:22 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 1, 2026, 11:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$EMN
Bearish
high confidence
Mentioned
$EMN
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$EMNBearishHigh
01

Why it matters

The earnings miss and guidance cut drove a 2% share decline, highlighting short-term downside risk.

02

Market read

Fresh earnings data with guidance change provides actionable insight for traders.

03

What to watch

DOE circular economy award may provide long-term upside despite short-term miss.

Relevance 8/10Novelty 8/10Timing: post-market today

Background

Eastman Chemical posted Q3 2026 results with revenue slightly below estimates and adjusted EPS of $1.84 versus $1.94 consensus.

Company-level read

Ticker impact

$EMNBearishHigh confidence
Context

Eastman Chemical reported Q3 2026 earnings miss and cut full-year cash flow guidance.

Expected impact

likely pressure as market prices in the earnings miss and reduced cash flow outlook

Evidence & confidence

The company missed EPS expectations and cut operating cash flow guidance, prompting a 2% stock decline.

Market effects

Specialty chemicals sector may see broader pressure from earnings miss.

U.S. market may see slight pullback in materials stocks.

Limited to investors tracking chemical manufacturers.

Counterpoint

Margin expansion could support a rebound if raw material costs stabilize.

Key entities

  • Eastman Chemical Company

    Specialty chemicals manufacturer reporting Q3 2026 results.

Related articles

$EMNMed

Goldman Sachs cuts Eastman Chemical stock price target on margin pressures

Goldman Sachs reduced its price target for Eastman Chemical (NYSE:EMN) to $72 from $73, citing Q3 earnings misses and margin pressures. The company reported adjusted EPS of $1.84 and adjusted EBIT of $305 million, both below expectations. Eastman Chemical also lowered its full-year 2026 adjusted EPS guidance to $6.00-$6.20, below consensus. The stock trades at $66.53, with a P/E ratio of 17.27 and a market cap of $7.61 billion.

$EMNMed

Eastman Chemical Co (EMN) (Q3 2026) Earnings Call Highlights: DOE Grant Restored

Eastman Chemical (EMN) discussed Q3 2026 earnings, noting restored DOE grant support for expansion projects, with DOE covering up to 50% of CapEx. CEO Mark Costa expects the second plant to cost less due to acquired assets. Propylene-propane spread is expected to narrow, adding $30M-$40M to 2027 earnings. Advanced Materials faces a $30M Q4 headwind, with January price increases aiming to offset costs. Operational delays impacted Q3 results, but lines are now running well.

$EMNMed

What Eastman Chemical (EMN) Said on Its Q3 Earnings Call

Eastman Chemical (EMN) expects circular-economy revenue growth to continue, aiming for $100M+ in 2027. It lowered its full-year operating cash flow forecast to $850M due to inflationary pressures. Advanced Materials faces Q4 cost pressures but anticipates price increases in 2027. Volume growth is expected in several segments, with a new ethylene-to-propylene unit planned for 2028.

$EMNMed

DOE reinstates $375 million Eastman award

The U.S. Department of Energy (DOE) reinstated a $340 million award to Eastman Chemical Company for its molecular recycling projects, after initially canceling a $375 million award. The updated plan includes increasing capacity at its Kingsport plant and repurposing underutilized U.S. recycling infrastructure. Eastman expects $100 million in incremental revenue growth in 2026 and over $100 million in 2027 from its Kingsport plant, according to the company.